Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-04

Clinical Trial Update: Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study

View source ↗

Summary

A post-market study evaluating Abbott's Brio deep brain stimulation system for Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brio Deep Brain Stimulation System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Parkinson Disease | Status: WITHDRAWN